Photobiomodulation with Near Infrared Light Helmet in a Pilot, Placebo Controlled Clinical Trial in Dementia Patients Testing Memory and Cognition.

Alzheimer's disease (AD) is a common, chronic expensive debilitating neurodegenerative disease with no current treatments to prevent the physical deterioration of the brain and the consequent cognitive deficits. The current pathophysiology of Alzheimer's disease is the accumulation of neurofibrillary tangles (NFTs) of hyperphosphorylated tau protein and amyloid-beta (Aβ) plaques. Antibody therapy of Tau and Amyloid beta, vaccines and other methods to decrease Tau and or Amyloid have not been successful after considerable pharmaceutical and biotech efforts. For example, Eli Lilly announced a major change to its closely watched clinical trial for the Alzheimer's drug solanezumab which failed to reach statistical significance. Recently, a report on animal models using photomodulation with near infrared light to treat AD pathology in K369I tau transgenic model (K3) l engineered to develop neurofibrillary tangles, and the APPs/PSEN1dE9 transgenic model (APP/PS1) to develop amyloid plaques. Mice were treated with NIR 20 times over a four-week period and NIR treatment (600-1000 nm) was associated with a reduction in the size and number of amyloid-β plaques in the neocortex and hippocampus. We now report a small pilot double blind, placebo-controlled trial (n=11) 6 active, 3 controls and 2 dropouts assessing the effect of 28 consecutive, sixminute transcranial sessions of near infrared (NIR) stimulation using 1060-1080 nm light emitting diodes. Subjects were independently diagnosed with dementia conducted in an outpatient behavioral healthcare clinic. IRB approval was obtained through the Quietmind Foundation's institutional review Board (IRB). Results showed changes in executive functioning; clock drawing, immediate recall, praxis memory, visual attention and task switching (Trails A&B) as well as a trend of improved EEG amplitude and connectivity measures. Neuroplasticity has also been reported with NIR light stimulation and mitochondrial enhancement.

[1]  Luis Carrasco,et al.  Different Brain Regions are Infected with Fungi in Alzheimer’s Disease , 2015, Scientific Reports.

[2]  Daniel M. Johnstone,et al.  Photobiomodulation with near infrared light mitigates Alzheimer’s disease-related pathology in cerebral cortex – evidence from two transgenic mouse models , 2014, Alzheimer's Research & Therapy.

[3]  J. Cummings,et al.  Alzheimer’s disease drug-development pipeline: few candidates, frequent failures , 2014, Alzheimer's Research & Therapy.

[4]  Ross Zafonte,et al.  Significant improvements in cognitive performance post-transcranial, red/near-infrared light-emitting diode treatments in chronic, mild traumatic brain injury: open-protocol study. , 2014, Journal of neurotrauma.

[5]  A. Antal,et al.  Neuroplastic effects of transcranial near-infrared stimulation (tNIRS) on the motor cortex , 2015, Front. Behav. Neurosci..

[6]  George Perry Faculty Opinions recommendation of Alzheimer's disease - a neurospirochetosis. Analysis of the evidence following Koch's and Hill's criteria. , 2011 .

[7]  B. Huisa,et al.  The Evolution of Transcranial Laser Therapy for Acute Ischemic Stroke, Including a Pooled Analysis of NEST-1 and NEST-2 , 2010, Current cardiology reports.

[8]  J. Miklossy,et al.  Alzheimer's disease - a neurospirochetosis. Analysis of the evidence following Koch's and Hill's criteria , 2011, Journal of Neuroinflammation.

[9]  R. Swerdlow,et al.  The Alzheimer's disease mitochondrial cascade hypothesis. , 2010, Journal of Alzheimer's disease : JAD.

[10]  J. Schneider,et al.  National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease , 2012, Alzheimer's & Dementia.

[11]  Hong-pyo Kim Lightening up Light Therapy: Activation of Retrograde Signaling Pathway by Photobiomodulation , 2014, Biomolecules & therapeutics.

[12]  Michael R Hamblin,et al.  Potential for transcranial laser or LED therapy to treat stroke, traumatic brain injury, and neurodegenerative disease. , 2011, Photomedicine and laser surgery.

[13]  T. Nichols Hyperphosphorylation of Tau Protein in DownâÂÂs Dementia andAlzheimerâÂÂs Disease: Methylation and Implications in Prevention andTherapy , 2014 .

[14]  A. Juby,et al.  The value of clock drawing in identifying executive cognitive dysfunction in people with a normal Mini-Mental State Examination score. , 2002, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[15]  S. Joshi,et al.  Alzheimer’s Disease: A Novel Hypothesis Integrating Spirochetes, Biofilm, and the Immune System , 2016 .

[16]  Michael R Hamblin,et al.  Role of Low‐Level Laser Therapy in Neurorehabilitation , 2010, PM & R : the journal of injury, function, and rehabilitation.

[17]  Basavaraj Hooli,et al.  A three-dimensional human neural cell culture model of Alzheimer’s disease , 2014, Nature.